Related Experiment Video
Updated: May 6, 2026
05:17
Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease
Published on: November 28, 2025
556
Delayed gastric emptying in Parkinson's disease
Sarah Marrinan1, Anton V Emmanuel, David J Burn
1Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom.
Summary
Parkinson's disease (PD) frequently causes delayed gastric emptying due to impaired motility, impacting levodopa absorption and treatment efficacy. Understanding this link is crucial for managing PD symptoms and therapeutic outcomes.
Area of Science:
- Neurology
- Gastroenterology
- Pathology
Background:
- Gastrointestinal symptoms, particularly impaired motility leading to delayed gastric emptying, are prevalent in all stages of Parkinson's disease (PD).
- This condition is often underdiagnosed in clinical practice despite its early and late-stage occurrence in PD patients.
- Delayed gastric emptying significantly affects levodopa absorption and efficacy, contributing to motor fluctuations in long-term therapy.
Purpose of the Study:
- To explore the pathological basis of delayed gastric emptying in Parkinson's disease.
- To discuss the implications of delayed gastric emptying for levodopa therapy and PD pathogenesis.
- To review the role of ghrelin as a potential therapeutic agent for delayed gastric emptying and as a neuroprotective agent in PD.
Main Methods:
- Review of pathological findings in the enteric nervous system and brainstem nuclei associated with PD.
- Analysis of neurohormonal mechanisms within the brain-gut axis.
- Consideration of recent research on ghrelin in PD and gastric emptying.
Main Results:
- Delayed gastric emptying in PD is multifactorial, linked to Lewy pathology in the nervous system.
- Abnormal gastric pathology is relevant to the broader understanding of PD etiology.
- Ghrelin shows potential therapeutic benefits for delayed gastric emptying and neuroprotection in PD.
Conclusions:
- Delayed gastric emptying is a significant, often unrecognized, complication of Parkinson's disease with major therapeutic implications.
- Understanding the brain-gut axis and hormones like ghrelin is vital for novel PD treatments.
- Gastric pathology offers insights into the pathogenesis and management of Parkinson's disease.
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
Related Concept Videos
01:16Gastric Emptying
5.5K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
5.5K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
01:11Pyloric Obstruction
81
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
81
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K